Professional Documents
Culture Documents
2010
Arterialbasedcontinuouscardiacoutputmeasurement factorfiction
HermannGilly,PhD
DepartmentofAnaesthesia,GeneralIntensiveCareMedicineandPain Therapy
MedicalUniversityVienna,Vienna,Austria
APCOcomparedwithGoldstandard
26.01.2010
Whyhemodynamicmonitoring? WhyCardiacoutput(CO)measurement?
Oxygenhastobecontinuouslydeliveredtothetissuesfor sustainablecellularfunction
Invasiveversuslessinvasivehemodynamicmonitoring
Mostinvasivecontinuous
Em/USflowprobearoundaortaorpulmonaryartery
Invasive(quasicontinuous)
Continuous(lessinvasive)
Lessinvasive,intermittent Noninvasive,continuous
Transthoracicbioimpedance
AIM:minimally(=less)orevennoninvasivecontinuousCOmeasurement
26.01.2010
MethodsforCardiacOutputmeasurement
Inputoutputbalance
Directmeasurement
I d di h Impedancecardiography Pulsecontour
Modelbasedmethods
Ficksprinciple oxygenuptake
Intermittentatbest,slowresponseassteadystateisrequired,invasiveca
26.01.2010
Thermodilution Bolustechnique
pulmonaryTD
transpulmonaryDD
normalcardiacoutput
PACGoldstandard Bolusthermodilution
Primaryparameter:timecourseoftemperatureinpulmonaryarteryorinaperipheralartery afterinjectinganamountofcold
Influencedby:
temperaturechangesduetosimultaneousinfusions appropriatemixing injection ,p ventilation,phase T siteofmeasurement nofinaloffset propertiesofcatheter possiblelossofindicator(extravasal) high/lowflowsituation (softwarerelease)
26.01.2010
FrombolusTDtocontinuousTD (vigilancemonitor)
Continuouspulmonarythermal(heat)dilution clinicalvalidationincomparisontocoldbolusTD
IntelliCath
OptiQ
acceptable
(CCO+TD)/2(L/min)
(CCO+TD)/2(L/min)
C Zllner, et al: Continuous cardiac output measurements do not agree with conventional bolus thermodilution cardiac output determination. CAN J ANESTH 2001 48: 11 ; 11431147
26.01.2010
F Mielck, W Buhre, G Hanekop, T Tirilomis, R Hilgers, H Sonntag. Comparison of Continuous Cardiac Output Measurements in Patients After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, Vol 17, No 2 (April), 2003: pp 211216
FeaturesofPAC
(TD,DD,bolus&cont)
CurrentstatusofPAC
Controversial results from large studies about the advantage over CVC
Probably reserved for patients with significant cardiac pathology/major morbidities (septic shock, large fluid shifts)
TDCO:Overallaccuracy1015%
26.01.2010
Basisforarterialpressurebasedpulsecontourcardiacoutput:
describingthe(left)ventricularpump
Q(t)Flow
WINDKESSSELMODEL
Frank's Windkessel - describes the hemodynamic of the arterial system in terms of resistance and compliance Peripheral resistance is calculated according to R=(pao,mean pven,mean) CO pao,mean CO
pao,mean - mean aortic pressure pven,mean -mean venous pressure CO- Cardiac Output
Nico Westerhof.ThearterialWindkessel.SpecialIssueReview.MedBioEngComput. 14
26.01.2010
accountingformoredetails
26.01.2010
TheWindkesselmodel
FirstmodelbyWesseling
AddingtheCompliance
R:totalsystemicperipheralresistance(SVR);Z:characteristicimpedanceoftheproximal aorta;C:Windkesselcomplianceoftheaorta
Lessinvasivepresasurepulsebasedquasicontinuous COmethods
PiCCO system (Pulsion Munich GER) (Pulsion, Munich, Modelflow (Finapres Medical Systems, Amsterdam, NL) PRAM (Mostcare FIAB SpA, Florence, IT) LiDCO plus/PulseCO system (LiDCO Ltd, Cambridge, UK)
Howtoaccountforthecharacteristicimpedance? H f h h i i i d
26.01.2010
Q(t)
Howtoaccountforthecharacteristicimpedance?
PiCCO: combines transpulmonary thermodilution for calibration and arterial PiCCO plus Aufbau pulse contour analysis 2nd sw-version: adapted algorithm: analyzes shape of the pressure waveCentralvenousaccess
form, accounting for individual compliance and systemic vascular resistance
Injectate temperature
AP
AP 117
140 92
PCCI
CI HR SVI
3.24 78 42
stroke volume computed by integrating the systolic area under the arterial pressure waveform
Arterialtemperature
PULSIONpressuretransducer
For calibration the specific aortic impedance is required: calculated by comparison of the systolic area and thermodilution CO measured
20
10
26.01.2010
PiCCO vs PA-TD
References
#
Mean SD (l/min)
Range (l/min)
Bias SD (l/min)
PE
r ** Software Version
Irlbeck et al. Buhre et al Rdig et al. Zllner et al. Zll t l Rauch et al. Mielck et al. Gdje et al. Della Rocca et al. Felbinger et al. Sujatha et al. Halvorsen et al. Chakravarthy et al de Wilde et al. Button et al.
20 / 165 12 / 36 26 / 308 19 / 76 25 / 380 22 / 96 24 / 517 62 / 186 20 / 360 60 / 480 31 / 252 15 / 438 24 / 199 31 / 185 4.7 ? 6.6 1.7
-0.09 0.85 0.003 0.63 0.18 1.24 0.31 1.25 0 31 1 25 -0.14 1.16 0.40 1.30 39
0.93 0.88
0.88 0 88
1.x patients on ICU 1.x patients on ICU during coronary 1.x bypass surgery after cardiothoracic surgery patients undergoing 1.x HCPB post cardiac surgery after cardiothoracic 4.1 surgery undergoing liver 4.1 transplantation post cardiac surgery undergoing OPCAB surgery undergoing OPCAB 5.1 surgery undergoing OPCAB surgery undergoing OPCAB surgery 6.0 perioperative period
5.0 - 7.1
47
PEpercentageerror;accordingtoCritchley&Critchley<30%(!!!!)
Modelflow method Modelflow computes the beat-to-beat cardiac output from the radial artery pressure, after an initial calibration (thermodilution or ultrasound for velocity and aortic diameter determination). nonlinear, time-varying three-element model of aortic input impedance (modified Windkessel model) simulating the interaction between cardiac ejection and the aortic and peripheral systemic input impedance and the resulting reflected pressure
The nonlinear characteristics of the model parameters were studied post-mortem in human aortae by Langewouters et al. However, Jansen and van den Berg found considerable individual variations of the aortic cross sectional area (up to 30% compared with average values of Langewouters study).
Cardiac Output / Cardiac Index * ModelFlow
References # n Mean SD Range Bias SD
PE
r **
vs PA TD PA-TD
(l/min) (l/min) (l/min)
15
open heart surgical patients undergoing CABG 0.83 post CABG surgery undergoing CABG
54 / 436 4.9 0.9 3.0 - 7.7 -0.13 0.47 19 24 / 24 5.4 1.2 3.1 - 8.8 -0.08 0.70 12 2.5 - 7.1 0.00 0.37
24 / 199 4.8 ?
11
26.01.2010
beat-to-beat estimate of the cardiac output continuously analyzing the arterial blood pressure waveform. The algorithm is supposed to be independent of the arterial
measurement site.
For the analysis of the pressure trace a 3-step transformation by Jonas is used. 1) the transformation of the arterial pressure signal into a standardized volumetime waveform (done by an algorithm compliance with a lookup table). 2) in order to obtain cardiac output, the duration of the cardiac cycle and the stroke volume is calculated by autocorrelation 3) this result is calibrated by comparison with a LIDCO-measured value, which the manufacturer recommends to be done every 4 to 6 hours. This calibration
factor corrects for the arterial compliance for a given arterial blood pressure and for variations between individuals. Further details for the exact calculation are not provided
LiDCO-technique
12
26.01.2010
References #
Mean SD (l/min)
Range (l/min)
Bias SD (l/min)
PE
r **
Linton et al.
40 / 160
-0.25 0.5
5.55 ?
2.4 - 11.5 -0.5 0.7 3.4 - 8.5 0.05 0.6 0.76 1.93 3.4 - 13.2 -0.29 1.09
after major surgery post CABG surgery undergoing OPCAB surgery 2 hours after liver transplantation undergoing CABG
5.0 ?
2.5 - 8.9
0.17 0.69
PRAM/Mostcare
standard arterial radial or femoral catheter, Calibration with other techniques not required
beat-to-beat values of cardiac output based on the mathematical analysis of the arterial pressure profile changes
The algorithm is based on the principle of perturbations performing a beat-to-beat analyis of the whole arterial pressure wave morphology (instead of just the pulsatile systolic area) The diastolic minimum the systolic pressure the dicrotic notch and area).The minimum, pressure, points of perturbance are evaluated.
PRAM claims to consider aortic impedance, compliance and systemic vascular resistance, which are affecting the pressure signal, further details undisclosed.
Cardiac Output / Cardiac Index * PA-TD vs PRAM
References # n Mean SD (l/min) Range (l/min) Bias SD (l/min) PE r **
2.6 0.6 *
1.7 - 4.0 -0.15 0.35 * * 27 2.3 - 7.4 0.03 0.89 1.6 - 4.2 -0.03 0.42 * * 31 0.07 0.40 20
undergoing heart 0.88 catherization 0.88 undergoing CABG undergoing heart 0.85 catherization 0.87 undergoing CABG
13
26.01.2010
Slidetakenfrom:EdwardsLifesciencesWebsite,modified
Patentapplication:EdwardsLifesciences
14
26.01.2010
Slidetakenfrom:EdwardsLifesciencesWebsite,modified
Slidetakenfrom:EdwardsLifesciencesWebsite
15
26.01.2010
Slidetakenfrom:EdwardsLifesciencesWebsite
Slidetakenfrom:EdwardsLifesciencesWebsite
16
26.01.2010
ThesecretofthecalculationofAPCO(Vigileo)(takenfromthepatentsdescription)
11parameters1 11
Slidetakenfrom:EdwardsLifesciencesWebsite
17
26.01.2010
Slidetakenfrom:EdwardsLifesciencesWebsite
FlowtracversusICO
FlowtracversusCCO
CCOvsICO
Slidetakenfrom:EdwardsLifesciencesWebsite
18
26.01.2010
ChangesinCOduetolinedamping
Slidetakenfrom:EdwardsLifesciencesWebsite
Art.Radialis(original;ProbandH.L.)
Art.Radialis smoothed
10
11
Harmonicfrequencies
26.April2007
Druckmessung XAchse:ArbitrreEinheit
19
26.01.2010
Setkonfiguration
Eigen frequenz
Dmpfungs faktor
Flowtrac
38,8 39,5
0,188 0,170
38,4 38,9
0,175 0,175
mit BD-Kanle
24,2 25,0
0,236 0,241
22,5 21,8
0,261 0,262
Manecke,2005
20
26.01.2010
ClinicalvalidationofcontinuousAPCO(FCI) comparisontocontinuouspulmonarythermaldilution(Vigilance)
FCIandBCI
0.18
0.08
Mean(L/min/m2)
BZukunft:EvaluierungdesminimalinvasivenFloTrac/VigileoMonitoringsystemsankritisch krankenPatienten.ThesisCharit UniversittsmedizinBerlin.2008
21
26.01.2010
ComparisonofchangesinindividualconsecutivelymeasuredHIdata, obtainedfromFloTrac/VigileoandtranspulmonaryTD/PCA(PiCCO)
22
26.01.2010
Mean SD (l/min)
Range (l/min)
PE
r ** Software Version
Sander et al Button et al. Mayer et al Manecke and Auger Opdam et al. Prasser et al. Breukers et al.
30 / 120 31 / 185 40 / 244 50 / 295 6 / 218 20 / 164 20 / 56 5.9 1.15 5.5 0.85 3.4 - 9.8 3.3 - 8.8 2.8 0.65 * 2.4 - 9.3 1.6 - 4.9 * 2.8 - 9.6
54
0.53 1.07
0.25 1.13 0.46 0.58 * 0.55 0.98 0.21 1.02 * 0.02 1.49 -0.14 1.00 -0.15 0.33 0.35 49.3 0.58 36 0.74 46 0.53
perioperative period cardiac surgical patients post cardiac surgery post cardiac surgery
1.0
1.03
critically ill in a neurosurgical ICU post cardiac surgery undergoing OPCAB surgery
Chakravarthy et al 15 / 438 Cannesson et al. 11 / 166 McGee et al Staier et al. Mayer et al. Metha et al Matthieu et al. 84 / ? 30 / 120 40 / 282 12 / ? 20 / 400 2.5 0.55 * 4.5 1.33 5.5 1.0 1.2 - 4.1 * 2.8 - 7.7 2.1 - 9.5 4.7 0.95 5.9 ? 1.9 - 8.2 3.1 - 9.2
undergoing CABG critically ill patients on ICU aortic valve replacement undergoing CABG undergoing OPCAB surgery undergoing liver transplantation
Conclusion
All currently available noninvasive arterial pressure based CO monitors have advantages and limitations.
With an increasing number of clinical studies being published on the applicability, suitability, and clinical utility of these monitors their use should continue to gain popularity. However, evaluation of changes and direction of changes essential (!)
When using these monitors in conjunction with the administration of fluids and vasopressors to specific therapeutic end points (goal directed therapy) there limitations should be kept in mind. Whether patient care and outcome may be improved using the less invasive state of the art devices presently available remains questionable. True continuous cardiac output : no end in sight yet at present more fiction than fact in dynamic conditions#
#personalview
23
26.01.2010
ThankYouforYourattention!
24
26.01.2010
25
26.01.2010
DLahner,BKabon,CMarschalek,AChiari,GPestel,AKaider,EFleischmann,HHetz.Evaluation ofstrokevolumevariationobtainedbyarterialpulsecontouranalysistopredictfluid of stroke volume variation obtained by arterial pulse contour analysis to predict fluid responsivenessintraoperatively.BritishJournalofAnaesthesia doi:10.1093/bja/aep200
Results. Twenty patients received 67 fluid boluses. Fiftytwo of the 67 fluid boluses administered resulted in fluid responsiveness. SVV achieved an area under the ROC curve of 0.512 [CI 0.320.70]. Conclusions.Thisprospective,interventionalobserverblindedstudydemonstrates thatSVVobtainedbyAPCO,usingtheFloTrac/Vigileo system,cannotserveasa reliablepredictor offluidresponsivenessinthesettingofmajorabdominal reliable predictor of fluid responsiveness in the setting of major abdominal surgery.
26
26.01.2010
TranspulmonaleThermodilution: Nach zentralvenser Injektion desIndikators misst ein Thermistor inder Spitze Herzzeitvolumen des arteriellen Katheter dieTemperaturvernderungen stromabwrts. DasHerzzeitvolumenwirddurchdieAnalysederThermodilutionskurvenach einemmodifiziertenStewartHamiltonAlgorithmusberechnet.
Temperaturverdnnungskurve Bolusverfahren
Tb Injektion
HZV TD
(T Ti ) Vi K b Tb dt
78
Thermodilution Bolustechnique
Calculationof areaunder curve(AUC) curve (AUC) mittels Extrapolation des abfallenden Kurventeils, Fitting
27
26.01.2010
28
26.01.2010
29
26.01.2010
PiCCO PiCCO-Technology combines transpulmonary thermodilution for calibration and arterial pulse contour analysis.
inline injectate temperature sensor in a central vene 4-French thermistor-tipped arterial pressure catheter (peripheral artery: femoral, axillary, brachial)
PiCCO
Wesseling et al.
stroke volume computed by integrating the systolic area under the arterial pressure waveform. For calibration the specific aortic impedance is required: calculated by comparison of the systolic area and thermodilution CO measured. 2nd software generation: adapted algorithm: analyzes the shape of the pressure waveform, taking into account the individual compliance and systemic vascular resistance
30